AMA, Sling Health expand engagement with physicians and entrepreneurs
The AMA and Sling Health expanded their joint efforts to allow physicians to inspire technologies that resolve unmet needs in health care.
AMA statement on Pentagon's ban on transgender in military
As Pentagon's ban on transgender in military goes into effect, AMA says no medical basis for referring to gender transition as a “deficiency."
AMA supports FDA’s changes to prescription opioids labels
AMA welcomes FDA including tapering guidance on prescription opioid labels, changes mirror points that AMA has emphasized in efforts to end the opioid epidemic.
AMA applauds congressional action on prescription drug transparency
The AMA believes in transparency in prescription drug pricing, and we are pleased the House Ways & Means Committee moved the issue forward.
AMA expansion of national effort creating medical school of the future
Leaders from 37-medical school consortium, convene for meeting on building a pipeline of physicians whose racial and ethnic background reflect needs of patients.
District of Columbia takes important step to reverse opioid epidemic
The MSDC and the AMA applauded the mayor’s office for removing prior authorization for medications to treat opioid use disorder.
Amidst growing measles outbreaks, AMA urges public to get vaccinated
Reminds physicians to discuss the safety and efficacy of vaccines with patients, and educate them on health risks associated with not vaccinating children.
UNH and the AMA collaborate to address access to better health
UNH and AMA support data use for social determinants of health to improve social services referrals and build efforts to help the underserved get health care.
AMA: New Jersey shows leadership to help end opioid epidemic
The AMA commended NJ Gov. Murphy and state Human Services Commissioner Johnson for helping end barriers to treatment for patients with opioid use disorder.